SAN FRANCISCO (AFX) -- Home Diagnostics Inc. on Monday filed to raise up to $115 million in its initial public offering. The Fort Lauderdale, Fla.-based developer of supplies for diabetics has applied for its shares to list on the Nasdaq under the symbol 'HDIX.' The lead underwriters are JPMorgan and Piper Jaffray. This story was supplied by MarketWatch. For further information see www.marketwatch.com.